|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Astelin (azelastine hydrochloride) Nasal Spray, Wallace NDA 20-114/S-005 5/30/00 6/6/00
Astelin Indications: Treatment of the symptoms of seasonal allergic sneezing, and nasal pruritus in adults and children 5 years and older (NOTE: Previously approved for 12 years and older).
Astelin (azelastine hydrochloride) Nasal Spray, Wallace NDA 20-114/S-006 OPTIVAR (azelastine hydrochloride ophthalmic solution), 0.05%, ASTA Medica, NDA 21-127 5/22/00 5/23/00 5/23/00 2/15/02
Optivar Indications: Treatment of itching of the eye, associated with allergic conjunctivitis. AZELASTINE HYDROCHLORIDE Solution/Drops; Ophthalmic 0.05% OPTIVAR MEDPOINTE HLC
020114 AZELASTINE HYDROCHLORIDE Spray, Metered; Nasal 0.125MG BASE/SPRAY ASTELIN MEDPOINTE HLC OPTIVAR (azelastine hydrochloride ophthalmic solution), MedPointe, Labeling Revision
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|